@EASLedu
brings you the latest on
#liver
research & education. Visit
#EASLCampus
-----------------
EASL does not express any political opinion.
RT ≠ endorsement
📢 Are you ready for the new
#EASLQuiz
?
🔎Look at this follow up question of the 40-year-old male patient case seen few weeks ago and check your Guidelines knowledge!
➡️
@EASLnews
#livertwitter
🥳🙌Finishing with some numbers! We reached over 25 Million impressions, thanks to you all for your great interactions and tweets! Thank you to the delegates, the chairs, speakers, poster presenters and sponsors for making the
#ILC2020
a success! See you in Amsterdam
#ILC2021
Live from the
#ILC2020
#EASLstudio
backstage! Don't forget to adress your questions to the evening and morning sessions using the
#EASLstudio
hashtag
Wishing you a great digital
#ILC2020
Frederik Nevens demonstrating that combination of OCA and Bezafibrate (BZF)
1⃣Induces biochemical remission in patients
2⃣Reduces the incidence of
#pruritus
3⃣Is better than BZF monotherapy
#EASLCongress
#LiverTwitter
Thanks to all for attending, sharing and interacting through
#IlC2018
and making this
#EASL
Congress a great success!!! We have reached over 35 million impressions!! 😀🙌👏 Safe travels ✈️🚆and see you in Vienna
#ILC2019
📢Hear ye, Hear ye!
We have a new Social Media Advisor!
Join us in welcoming Dr Ahmed Elsharkawy!👏 👏
🤝 We look forward to working with him in sharing the hidden gems
#Livertwitter
has to offer!
Follow him 👉
@aelsharkawy75
Bio 👉 at
@EASLnews
Landmark paper session with
@dufour_jf
challening
@ProfJohnDillon
on his paper on intelligent liver function testing (iLFT): a trial of automated diagnosis and staging of liver disease in primary care, great discussions!
#ILC2020
#livertwitter
📢
#EASL
is organising together with
@JHepatology
2 webinars on decompensated
#cirrhosis
based on the upcoming journal supplement!
Webinar1: Disease Trajectory & Pathophysiology, 25 May.
Webinar2: Management & Liver Transplantation, 1 June.
Register now:
Thanks to the organisers, speakers, chairs & attendees for making the second
#EASL
#NAFLDsummit
a great success!! Thanks to the 119 twitter participants for interacting & sharing: We reached 1 Million
#impressions
!! 👏🙌😀
Wishing you all safe travels and see you next year 🌞!
1⃣ Early diagnosis of HE is key:
✅Animal naming test❌PHES too long, any 🚗 accident?
2⃣ Blood ammonia test to rule out other causes of HE
3⃣ Lactulose favoured, rifaximin possible
4⃣ Brain imaging if cofactors
5⃣ Optimise diet
6⃣ AWARENESS 🆙
@ISHENliver
#LiverTwitter
@EASLnews
📢
@DocBerza
on portal hypertension:
👉frequent in patients with HCC
👉leads to poor outcomes
👉non-invasive tests are not always reliable (i.e in compensated patients)
👉novel methods are coming but validation studies are needed
#LiverCancerSummit
2023
@EASLnews
💡Advice from
@MassimoPinzani
to the
#YoungInvestigators
❌Don't study
#NAFLD
✅Go to areas with less current developement
💭Consider Big data - new technologies
👐Be open-minded and interdisciplinary
🧚♀️Find the RIGHT mentor - the wrong mentor could clip your wings
#ILC2021
🎉 WE DID IT!
The
#EASLCongress
2023 has been a remarkable event, bringing together experts, researchers, and healthcare professionals from around the world to share insights and advancements in liver research and clinical practice. From the innovative sessions and workshops…
📢
@CancerInflam
explained why metagenomics should be used in liver cancer research:
👉Non-invasive test for NASH staging
👉Spatial distribution of bacteria in tumours
👉Identify microbial signature in cohort & mycobiome
#LiverCancerSummit
2023
#Livertwitter
@EASLnews
That’s a wrap! 🎬
Thank you very much🙏
➡️ the course organisers and local team of the Hospital Universitario Ramón y Cajal👨⚕️
➡️ our group of international students, coming from 15 different countries 🌍 for this
#EASLSchool
on cirrhosis
➡️ special guest
@ReibergerThomas
Is anticoagulation indicated in patients with cirrhosis and occlusive portal vein thrombosis❓
➡️ Prof. Agustín Albillos is answering this important question for the students of the
#EASLSchool
in Madrid 🇪🇸
#LiverTwitter
@EASLNews
@DigestivoHRyC
#EASLStudio
: Statins for cirrhotic patient?
👉 It depends on the dose: simvastatin 40mg is unsafe
👍 Better for compensated patients
❌Not recommended to prevent ACLF
👉Give statins if there are any indications for it
👍 Ok in compensated patient with MASLD with close monitoring
Nice talk of Dr Matías A Avila showing the importance of epigenetic alterations in hepatocarcinogenesis and why this could bring to new treatment strategies!
👉Questions? Use the Q&A tool
#LiverCancerSummit
2022
@EASLnews
📢🧪🧫New on
#EASLcampus
!
"Basic techniques in experimental hepatology at a glance"!
Discover scientific video protocols in the fields of hepatology &
#liver
-related
#research
!
Watch the 1st video on establishing organoids from patient-derived tissues!
About last night 🌙
Walking city tour of Madrid lead by Prof. Agustín Albillos 👣🇪🇸
Visit of Puerta del Sol, Plaza Mayor, Plaza de España and much more 👀🙌
@EASLnews
@DigestivoHRyC
Sugar-sweetened beverages & ⬆️
#liver
lipogenesis?
🥤It's all in the fructose
What are the implications?🤔
Hear the authors' take at the
#EASLJC
🗓️Tomorrow, 18:00 CET
More info👉
@EASLnews
@JHepatology
ℹ️ Dietary changes are very effective in reducing
#Steatosis
and
#NAFLD
"We need a integrated public health approach in order to reduce stigma and discrimination in patients with chronic liver disease. We need to treat everyone based on their needs"
@JVLazarus